comprehensive -WSS

comprehensive

author：leisure time 2025-10-01 15:28:39 - browse：15878

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday released a new accounting of artificial intelligence tools cleared for use in health care, adding scores of new products designed to reshape care in several areas of medicine.

The update included 171 new products that use artificial intelligence and machine learning, including 155 authorized since August of 2022. The agency’s data indicate that, after a lull during the Covid-19 pandemic, the number of authorized devices in 2023 is expected to increase by more than 30% over the prior year.

The list of AI devices was first published after a STAT investigation reported that the FDA had failed to keep the public informed on its regulation of AI devices, or crucial details on the tests undertaken to prove their safety and effectiveness. The summary documents that describe new AI devices often fail to break out the demographics of the patients they were tested on, or where the testing took place, which makes it difficult for clinicians and patients to understand their potential biases and weaknesses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： The EPA's new lead rule: How one expert crunched the numbers

hotspot

WSS

Pediatric cancer treatments threatened by a new FDA policy

JPM pitch from hospitals? Revenue streams outside of patient care

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Hospital chaplains balance Covid safety with patients’ spiritual needs

entertainment

comprehensive

explore

The high cost of giving birth even with insurance

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Supreme Court strikes down use of affirmative action

Profiling embryos to choose those with higher IQs is almost a reality

Hepatitis C has a cure — but many Americans still lack access to it

Stories you might have missed in 2023: health, science, medicine

Tori Bowie and the unacceptable rates of Black maternal death

As biotech industry slumps, bioscience job market is upside down

Anesthesiologist group: stop taking Ozempic before surgery

Will the market for weight loss drugs really reach $100 billion?

leisure time

Allen Institute goes after foundational questions, CEO Costa says

STAT Virtual Event: JPM Recap, Live!

Will the market for weight loss drugs really reach $100 billion?

What don’t we know about an Alzheimer’s drug side effect?

30 years of 'Listening to Prozac'

Physician assistants need a new name. Here's what it should be

hotspot

focus

hotspot

focus